Elan Corporation logo

Elan Corporation

Europe, Dublin, Ireland, Dublin

Description

Elan Corporation, plc is a biotechnology company committs to make a difference in the lives of patients and their families.

Investor Profile

Elan Corporation has made 4 investments, with 0 in the past 12 months and 50% as lead.

Stage Focus

  • Series C (25%)
  • Series B (25%)
  • Series A (25%)
  • Series Unknown (25%)

Country Focus

  • India (50%)
  • United Arab Emirates (25%)
  • United States (25%)

Industry Focus

  • Medical Device
  • Biotechnology
  • B2b
  • Health Care
  • Marketplace
  • Oncology
  • Pharmaceutical
  • Medical
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Elan Corporation frequently co-invest with?

Kuwait Life Sciences Company
Asia, Al Kuwayt, Kuwait, Safat
Co-Investments: 1
Co-Investments: 2
KI
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 2
HealthQuad
Asia, Delhi, India, New Delhi
Co-Investments: 2
Co-Investments: 1
Burrill & Company
North America, California, United States, San Francisco
Co-Investments: 1
CBC Group
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
Toppan Printing
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
Ackermans & van Haaren
Europe, Antwerpen, Belgium, Antwerpen
Co-Investments: 1

What are some of recent deals done by Elan Corporation?

Medikabazaar

Mumbai, Maharashtra, India

Medikabazaar is an online B2B marketspace for medical supplies and equipment.

B2BHealth CareMarketplaceMedical Device
Series BNov 18, 2019
Amount Raised: $15,567,427
Medikabazaar

Mumbai, Maharashtra, India

Medikabazaar is an online B2B marketspace for medical supplies and equipment.

B2BHealth CareMarketplaceMedical Device
Series AOct 29, 2018
Amount Raised: $5,000,000
NewBridge Pharmaceuticals

Dubai, Dubai, United Arab Emirates

Newbridge Pharmaceuticals is a pharmaceutical and medical device company engaged in developing oncology and supportive care products.

BiotechnologyMedical DeviceOncologyPharmaceutical
Series CMay 29, 2013
Amount Raised: $48,000,000
Proteostasis Therapeutics

Cambridge, Massachusetts, United States

Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.

BiotechnologyMedicalTherapeutics
Series UnknownMar 25, 2011
Amount Raised: $20,000,000